PubMed ID:
18804555
Public Release Type:
Journal
Publication Year: 2009
Affiliation: Indiana University School of Medicine, Indianapolis, IN, United States.
DOI:
https://doi.org/10.1016/j.cct.2008.09.003
Authors:
Hoofnagle J,
Kleiner DE,
Chalasani NP,
Kowdley KV,
NASH CRN Research Group,
Robuck PR,
Sanyal AJ,
Tonascia J,
Unalp A
Studies:
Nonalcoholic Steatohepatitis Clinical Research Network
,
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis
Non-alcoholic steatohepatitis (NASH) is a common liver disease associated with obesity and diabetes. NASH is a progressive disorder that can lead to cirrhosis and liver failure. Insulin resistance and oxidative stress are thought to play important roles in its pathogenesis. There is no definitive treatment for NASH.